(Q52964187)

9 May 2018

title

Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy. (English)

1 reference

9 May 2018

1 reference

Sezer O

1

1 reference

9 May 2018

Niemöller K

2

1 reference

9 May 2018

Kaufmann O

3

1 reference

9 May 2018

Eucker J

4

1 reference

9 May 2018

Jakob C

5

1 reference

9 May 2018

Zavrski I

6

1 reference

9 May 2018

Possinger K

7

1 reference

9 May 2018

publication date

1 April 2001

1 reference

9 May 2018

European Journal of Haematology

published in

1 reference

9 May 2018

volume

66

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

238-244

1 reference

9 May 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

New perspectives in clinical oncology from angiogenesis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

Angiogenesis in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

Bone marrow angiogenesis and progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

Vascular enumeration as a significant prognosticator for invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

7 January 2021

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

7 January 2021

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

7 January 2021

Vascular enumeration as a prognosticator for colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

7 January 2021

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

7 January 2021

Autologous stem cell transplantation for relapsed and primary refractory myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.066004238.X

7 January 2021

10.1034/J.1600-0609.2001.066004238.X

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

11380603

1 reference

9 May 2018